Overall, our data provide some insight into the clinical importance of the FOXO3 gene, and further investigation will aid in developing effective pharmacological approach in targeting FOXO3 and its associated pathway in breast cancer cases. This evidence concerns the gene FOXO3 and breast carcinoma.